In what health authorities are calling a game-changer, the United Kingdom has approved a long-acting HIV prevention injection to be administered every two months as an alternative to daily oral ...
Northwell Health is now offering a new injection that promises to reduce the risk of HIV and AIDS. Doctors say it will combat the disease's ongoing spread throughout the country. Over 100,000 people ...
– Approval Based on Phase 3 PURPOSE 1 and PURPOSE 2 Data that Showed ≥99.9% of Participants Remained HIV Negative on Twice-Yearly Injectable Yeztugo – – Yeztugo, Nearly 20 Years in the Making, ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new long-lasting prophylactic treatment for HIV-1 that is administered once every 6 months. Lenacapavir (Yeytuo, Gilead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results